DIAX
Get informed when a big investor buys or sells
+ FollowOvervalued by 100% based on the discounted cash flow analysis.
| Market cap | $512.77 Million |
|---|---|
| Enterprise Value | $512.76 Million |
| Dividend Yield | $1.20 (8.54%) |
| Earnings per Share | $1.44 |
| Beta | 0.74 |
| Outstanding Shares | 36,366,913 |
| P/E Ratio | 9.82 |
|---|---|
| PEG | 620.7 |
| Price to Sales | 7.05 |
| Price to Book Ratio | 0.88 |
| Enterprise Value to Revenue | 6.07 |
| Enterprise Value to EBIT | 4.34 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 34.21%▲ 1.28% |
|---|---|
| Total Invested | $189.86M▲ 6.44% |
| Investors Holding | 122▲ 12.00% |
No data
Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) is designed to offer regular distributions through a strategy that seeks attractive total return with less volatility than the Dow Jones Industrial Average (DJIA or “Dow30”) by investing in a...